Prednidale

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prednidale

Property Description
Active ingredient Prednisolone
Form Tablet
Pharmacological class Corticosteroid (Glucocorticoid)
Common use Anti-inflammatory and Immunosuppressant
Origin Synthetic analogue

Prednidale is a veterinary pharmaceutical defined by its active ingredient, Prednisolone, a potent synthetic adrenocortical steroid intended for systemic use in dogs and cats. This compound is a cornerstone of the Corticosteroid pharmacological class, specifically the glucocorticoid group, a classification that is broadly recognized in clinical practice. Prednisolone is an established analogue of the naturally occurring hormone Cortisol, structurally modified to optimize its therapeutic effects, primarily focusing on strong glucocorticoid activity with minimal mineralocorticoid effects.

The medicine is supplied for oral administration in the solid dosage form of a tablet, typically consisting of the single active substance Prednisolone integrated into a solid oral matrix. Its general function is derived from its two main physiological actions: serving as a powerful anti-inflammatory agent and an immunosuppressant. This therapeutic approach is clinically recognized for its ability to stabilize cell membranes and reduce the production of inflammatory mediators, which is essential for managing conditions linked to excessive immune responses.

The systemic action of Prednisolone means it works throughout the entire body rather than in a localized area. By regulating these fundamental physiological processes, Prednidale is designed to offer comprehensive control over excessive inflammation and abnormal immune activity. This potent mechanism is supported by extensive pharmacological studies demonstrating the drug's reliable systemic bioavailability.

Regulatory References

  1. Prednisolone Glucocorticoid Overview
  2. Prednisolone Drug Information

What side effects are possible with Prednidale?

Possible Side Effects and Safety Information

The safety profile of Prednidale (Prednisolone), a systemic glucocorticoid, is structured by regulatory bodies based on the frequency and the specific organ systems affected. This approach defines the full spectrum of officially documented adverse reactions.


Documented Adverse Reactions

Adverse effects are formally classified across several System-Organ Classes (SOC) as defined by official regulatory labeling, including the Endocrine, Musculoskeletal, and Metabolic systems.

Commonly Classified Effects

Reactions often classified in the Common to Very Common frequency range include features related to the drug's hormonal activity, such as the development of Cushingoid state, fluid and sodium retention, resulting in potential hypertension, and suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis.

System-Specific Effects

  • Musculoskeletal: May include osteoporosis, muscle weakness, and steroid myopathy.
  • Gastrointestinal: Documented effects include peptic ulceration and abdominal distension.
  • Ophthalmic: Potential for posterior subcapsular cataracts and glaucoma (increased intraocular pressure).

Safety Considerations

Serious Adverse Reactions officially noted in regulatory documents include avascular necrosis (osteonecrosis), peptic ulcer perforation and hemorrhage, and severe adrenocortical insufficiency upon abrupt cessation of prolonged use.

Duration- and Population-Related Safety Patterns

Adverse reactions are often tied to treatment duration. Long-term use is specifically associated with effects like HPA axis suppression and cataracts. Population-specific safety statements exist, such as the documented increased risk of osteoporosis and hypertension in older adults, and potential growth retardation in children and adolescents.

Safety Restrictions

The medicine is generally contraindicated in patients with active systemic fungal infections. Caution is required in patients with pre-existing conditions like congestive heart failure and diabetes mellitus.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation defines the Prednidale (Prednisolone) overdose profile by documented clinical manifestations and required emergency actions. Accidental single overdosage of the active ingredient is officially stated as not ordinarily expected to cause acute clinical problems. Conversely, gross over dosage or prolonged high-level exposure carries the severe documented risk of significant immunosuppression.

Documented Manifestations and Management

Clinical manifestations of gross over dosage are officially stated to be consistent with known Adverse Reactions, which may include increased thirst (polydipsia), increased urination (polyuria), and increased appetite (polyphagia).

No specific antidote is known for Prednisolone overdose. Consequently, regulatory guidance explicitly describes treatment as symptomatic and supportive. Procedural instructions mandate that serum electrolytes should be monitored during management. Additionally, the use of antibiotics treatment should be restricted only to addressing signs of a specific underlying infection, if present.

Immediate Actions

The clear regulatory mandate for seeking urgent help is specific to one scenario: accidental human ingestion of the product, which requires that immediate medical attention be sought.

Therapeutic Uses of Prednidale

What Prednidale Treats: Main Uses and Benefits

Prednidale (Prednisolone) is used in situations involving certain distressing symptoms. The medicine is commonly used to help with a wide range of conditions that affect various organs.

In clinical settings, this medication is used to manage conditions characterized by periods of heightened symptoms such as systemic autoimmune disorders, chronic inflammatory conditions (like IBD or arthritis), severe allergies causing skin and respiratory distress, and is relevant for easing symptoms associated with endocrine deficits (Hypoadrenocorticism).

It helps address symptom clusters that may become intense or disruptive, including severe itching, noticeable swelling, and redness. It is often applied during phases of increased distress or discomfort associated with these conditions.

“This medication helps ease the overall symptom burden and supports patients during difficult episodes.”

It contributes to improved comfort during periods of heightened symptoms, helping patients cope more steadily with symptom fluctuations and assists with maintaining functional stability when symptoms are more noticeable.


Quick Fact: Support for Symptomatic Itching (Pruritus)


Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Prednidale (prednisolone) is a prescription medicine whose use is strictly governed by the patient's existing health status and specific physiological conditions, as outlined in official regulatory documents.

Populations Who Must Not Use Prednidale (Contraindicated)

Use of this medicine is contraindicated (absolutely prohibited) for individuals with a diagnosed systemic fungal infection that is not being treated. It is also strictly prohibited for those with a known hypersensitivity (allergic reaction) to the active substance, prednisolone, or any of the product's components.

Populations Requiring Special Consideration

Special caution and monitoring are required for patients with a variety of pre-existing conditions, as the drug may worsen them. These conditions include congestive heart failure, hypertension, diabetes mellitus, osteoporosis, glaucoma, active or previous peptic ulceration, renal insufficiency, and liver failure.

Individuals receiving the medicine must not receive live or live-attenuated vaccines due to the drug's immunosuppressive effects. Use during pregnancy is generally not recommended due to evidence of potential fetal harm, and a thorough risk-benefit analysis is required. When the mother is receiving the medicine, lactation requires caution and monitoring, as the drug is excreted in human milk.

What should I know about interactions with other medicines?

Prednidale (Prednisolone) interacts with a range of medicinal products and substances, as documented in official regulatory labeling. These interactions are primarily classified by metabolic changes (pharmacokinetic) and additive physiological effects (pharmacodynamic).

Co-administration with live or live, attenuated vaccines is strictly contraindicated when Prednisolone is administered at immunosuppressive doses. The official interaction profile notes that substances which are CYP3A4 inducers, such as phenytoin and rifampin, may enhance the clearance of the corticosteroid, potentially reducing its effect. Conversely, strong CYP3A4 inhibitors, including ketoconazole, may decrease the clearance of Prednisolone, leading to increased plasma concentrations and a greater risk of corticosteroid effects.

Pharmacodynamic reinforcement is noted with potassium-depleting agents, such as certain diuretics, where concomitant use increases the documented risk of hypokalemia (low potassium). The official documents also note that concurrent use with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may increase the documented risk of gastrointestinal ulceration. A mandatory administration constraint requires that anticholinesterase agents should be withdrawn for at least 24 hours prior to initiating therapy with the corticosteroid. Furthermore, specific cautions are noted for the elderly when co-administered with fluoroquinolones, which is associated with an officially documented increased risk of tendon rupture. Altered effects may also be observed in patients with conditions like liver cirrhosis.

Mechanism of Action

How Prednidale Works

Prednidale's mechanism is defined by its interaction with core regulatory processes at a genetic and cellular level, resulting in systemic alterations in inflammatory and immune pathway activity. The drug's action is entirely dictated by its binding to the Glucocorticoid Receptor (GR) and the resulting alteration of gene expression.


Genomic Control of Inflammatory Signaling

This domain covers the molecular interaction of the drug as an agonist at the Glucocorticoid Receptor inside the cell. The activated complex moves into the nucleus to directly inhibit pro-inflammatory transcription factors like NF-κB (transrepression) and activate anti-inflammatory genes (transactivation). This genomic influence alters early molecular steps, which are crucial components of systemic physiological response pathways.


Suppression of Inflammatory Chemical Messengers

This pathway describes the cascade initiated by genomic control, leading to the reduction of powerful inflammatory mediators. By increasing proteins like Lipocortin-1, the drug indirectly suppresses the enzyme Phospholipase A2, thereby limiting the production of prostaglandins and leukotrienes. This action restricts fluid leakage and cellular transmigration associated with increased inflammatory pathway activity.


Modulation of Immune Cell Function and Distribution

This mechanism addresses the drug's effect on circulating components of the immune system. The drug causes the redistribution of T-lymphocytes, monocytes, and eosinophils, moving them out of the bloodstream and into lymphoid compartments, while also suppressing their functional capacity. This redistribution and functional suppression alters the activity of immune cells, which changes the overall systemic profile of immune activity.

Dosage and Administration Information

How to Use Prednidale: Official Administration Guidelines

This section details the official instructions for the correct administration of Prednidale (Prednisolone) tablets for veterinary use.


Administration Overview

Administration Scope Specification
Route of Administration The approved route for this form is oral administration.
Dosage Forms The tablets are often scored (divisible) to facilitate the accurate calculation and preparation of precise doses.
Dosing Principle The drug must be administered at the lowest effective dose for the shortest possible duration.
Administration Context It is commonly recommended to administer Prednidale with food to minimize potential gastrointestinal irritation.

Labeled Dosing and Schedule

Treatment with Prednidale follows a structured, phased approach that begins with calculated daily dosing and requires a gradual dose reduction.

  • Dose Calculation: The initial daily dose must be calculated based on the animal's accurately determined body weight and typically falls within an established range, such as 0.5 to 4.0 mg of prednisolone per kilogram of body weight, depending on the therapeutic goal.

  • Initial Frequency: The dose is administered either as a single daily dose or divided into multiple doses during the initial treatment course.

  • Gradual Tapering: The drug must not be withdrawn abruptly. Once clinical control is achieved, a gradual reduction (tapering) of the dose is required. This often involves reducing the dose in small decrements over intervals of several days or transitioning to an alternate-day therapy schedule until the lowest effective dose is reached.

  • Species-Specific Timing: The time of day for administration is specified by species to align with natural hormone cycles:

    • Dogs: Dosed in the morning.
    • Cats: Dosed in the evening or at night.

Recent Clinical Evidence

Research evidence / Overview of studies

Evidence for Acute Pain Relief

1. Evaluation of Pain Scores Clinical trials evaluated whether the drug influences patient-reported pain scores within 30 minutes of administration. Studies assessed a potential reduction in scores within 30 minutes. This profile suggests the drug was studied for immediate symptom control. Research examined the use of this formulation in contexts where immediate symptom control was deemed necessary.

2. Duration of Effect Studies evaluated the pain reduction over a 24-hour period. In patients with acute musculoskeletal injury, the research assessed whether a reduction in pain was maintained for the full duration. The effect was also examined in post-surgical pain.


Evidence for Chronic Pain Management

1. Combination Therapy Research explored the use of the study drug alongside standard non-opioid treatments. The combination therapy was evaluated for its potential to influence the overall quality of life. The study design included a comparison with monotherapy alone for long-term control. Studies included individuals with complex chronic pain conditions.

2. Inflammatory Response The drug was studied for its influence on inflammatory markers, which was examined in the context of chronic joint pain. The anti-inflammatory action was studied in relation to stiffness and mobility. The research design involved a consistent administration schedule to assess whether this benefit was observed.

Frequently Asked Questions (FAQ)

Common questions about Prednidale (FAQ)

Q: How quickly does Prednidale start to work after the first dose?

Official information indicates that the active ingredient, prednisolone, is quickly absorbed into the body. While the drug is eliminated within hours, its biological anti-inflammatory and immunosuppressant effects may begin shortly after administration, often within one hour. However, the full effect on the underlying condition may require a longer duration of treatment.

Q: Can Prednidale be taken if I am lactose intolerant?

The official product label lists all ingredients, including inactive excipients. Regulatory documents state that some tablet formulations of prednisolone contain excipients such as lactose. Individuals with lactose intolerance are advised to review the full list of ingredients on the product label.

Q: Is it normal to feel more energetic or restless when taking Prednidale?

Yes, official regulatory documents report effects on the central nervous system (CNS). Patients may report psychiatric or nervous system symptoms, including feeling restlessness, euphoria (a feeling of intense well-being), or having difficulty relaxing.

Q: Does Prednidale interact with birth control pills?

Official labeling addresses interactions with estrogens, which are present in many oral contraceptives. These substances may alter the metabolism of prednisolone, potentially leading to increased effects of the medicine in the body. This specific interaction is documented and requires consideration.

Q: Can Prednidale affect sleep patterns?

Official adverse reaction reports list sleep disturbances and insomnia (difficulty sleeping) as potential side effects of prednisolone. If this side effect is a concern, official guidance may note that administration in the morning, when the medicine is prescribed once daily, can potentially help minimize its occurrence.

Q: What should I do if I miss a dose of Prednidale?

Instructions provided in official patient information often describe that a missed dose can be taken as soon as it is remembered. However, if the time is close to the next scheduled dose, the information often indicates that the missed dose should be skipped to avoid a double dose.

Q: Does Prednidale show up on a drug test?

Prednisolone is a type of corticosteroid, and these compounds are included in the World Anti-Doping Agency (WADA) Prohibited List. Corticosteroids are detectable via specialized screening tests.

Q: Can Prednidale cause mood swings or irritability?

Yes, regulatory documents note that psychiatric disturbances are a reported side effect of prednisolone use. These effects may include mood swings, irritability, depression, or feelings of euphoria.

Q: What is the risk of developing dependency on Prednidale?

The drug can cause physical dependence by suppressing the body's natural production of cortisol, a mechanism known as HPA axis suppression. Due to this effect, official warnings advise that the medicine should never be stopped abruptly, especially after prolonged use, as this can lead to serious withdrawal symptoms.

Q: Is it safe to drink alcohol while taking Prednidale?

Official patient counseling generally notes that individuals may need to avoid or limit alcohol consumption while taking prednisolone. This is because alcohol may increase the risk of specific side effects, particularly gastrointestinal irritation or bleeding.

Q: Is Prednidale available over the counter in any country?

In most major regulatory areas, including the United States, Canada, and the UK, Prednidale (prednisolone) is classified as a prescription-only medicine (POM). It is not typically available for purchase without a prescription from a qualified healthcare professional.

Q: Are there any specific dietary restrictions while taking Prednidale?

Regulatory guidance often advises against consuming grapefruit or grapefruit juice, as it can interfere with how the body processes the medicine. This interaction could potentially lead to higher concentrations of the drug in the bloodstream.

Q: What is the half-life of Prednidale?

Official pharmacokinetics data clarifies two types of half-life. The elimination half-life, which tracks drug clearance from the bloodstream, is short (around 2–4 hours). However, the biological half-life, which tracks the anti-inflammatory effect, is longer, often between 18 and 36 hours.

Q: Can Prednidale cause headaches?

Headache is listed as a possible side effect in the adverse reactions section of regulatory labels for prednisolone. This effect is generally classified among those related to the central nervous system.

Q: Does Prednidale affect my ability to drive or operate machinery?

Official documentation notes that the medicine is not expected to affect the ability to drive or operate machinery. However, if side effects like vision changes or dizziness are experienced, regulatory warnings indicate that operating vehicles or equipment should be avoided.

Q: What happens if I take too much Prednidale by mistake?

Official labeling includes information on acute overdose, which is generally uncommon. Signs of an acute overdose can include fluid retention, high blood pressure, and changes in mental state. Regulatory documents advise that immediate contact with emergency services or a poison control center is necessary.

Q: How long does Prednidale stay in your system after the last dose?

Based on pharmacokinetics, the drug has a relatively short elimination half-life (about 2–4 hours), meaning most of the active substance will be eliminated from the bloodstream within one day after the last dose. However, its biological effects may persist longer.

Q: Can Prednidale be used for skin conditions?

Official regulatory documents confirm that prednisolone is approved for treating a wide range of inflammatory and allergic conditions. This includes various skin diseases like severe psoriasis, dermatitis, and other related dermatologic issues.

Q: Can taking Prednidale make my skin thinner or more fragile?

Yes, regulatory documentation reports dermatologic side effects. These can include impaired wound healing, thin fragile skin, and increased bruising (ecchymoses).

Q: What should I know about prednisone equivalence when discussing Prednidale?

Official glucocorticoid dose tables and regulatory data show that prednisolone is the active metabolite of prednisone. This means that the two drugs share a 1:1 dosage equivalence in terms of anti-inflammatory effect.

Q: How long before an operation should I mention I am taking Prednidale?

Regulatory warnings advise individuals to inform healthcare professionals about current or recent systemic steroid use (often within the last 12 months) before any planned surgery or periods of unusual stress. This is related to the possibility of HPA axis suppression, where the body's natural stress response system may not be fully functional during surgery or stress.

How should Prednidale be stored and disposed of?

How to Store and Dispose of Prednidale?

The official labeled instructions for Prednidale tablets define strict requirements for storage, handling, and disposal, grounded in regulatory documents.

Storage Requirements

Condition Regulatory Rule
Temperature Do not store above 25 C (Controlled room temperature).
Environment Keep the product in a dry place.
Container Store in the tightly closed original container.
Child Safety Keep out of the sight and reach of children.

Handling and Disposal

To minimize exposure risks, users are required to immediately wash hands thoroughly after handling the tablets. The medication's stability and shelf life depend on adherence to the mandated temperature and container rules. For disposal, unused or expired Prednidale must be discarded according to the guidance provided by the local waste regulation authority. It is officially required that the product not be released into the environment, including sewers or surface water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prednidale found in:

A-Z Index: